Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Safety and Efficacy of BG9924 in Subjects With RA Who Have Participated in Study 104RA202.

NCT00664573 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT00664573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00664573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Safety and Efficacy of BG9924 in Subjects With RA Who Have Participated in Study 104RA202.
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2007
Completion date
October 31, 2008
Enrollment
339 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis